v-Maf Activators encompass a diverse group of chemical compounds that indirectly augment the functional activity of v-Maf through a variety of signaling pathways and cellular mechanisms. Phorbol 12-myristate 13-acetate (PMA) enhances v-Maf activity by activating protein kinase C, which can lead to the phosphorylation and modulation of transcription factors and associated proteins, thus influencing v-Maf's transcriptional control over target genes. Forskolin, Isoproterenol, and Dibutyryl cyclic AMP (db-cAMP) share a common mechanism of increasing intracellular cAMP levels, thereby activating protein kinase A (PKA). Activated PKA may then target substrates that can have a positive regulatory effect on v-Maf, such as enhancing its affinity for DNA or interaction with coactivators. Retinoic acid can modulate v-Maf activity by influencing its heterodimerization with retinoic acid receptors, which shapes the transcriptional response of v-Maf target genes. Epigallocatechin gallate (EGCG) and Curcumin exert their effects by modifying the epigenetic landscape, either through inhibition of DNA methyltransferases or by modulating multiple signaling pathways, potentially creating a more favorable environment for v-Maf function.
The histone acetylation status, which is essential for an accessible chromatin conformation, is influenced by compounds like Trichostatin A (TSA), Sodium butyrate, and Sulforaphane, which inhibit histonedeacetylases (HDACs). This inhibition results in a relaxed chromatin structure, potentially enhancing the transcriptional activity of v-Maf by facilitating its access to DNA binding sites. Similarly, S-Adenosylmethionine (SAM) influences the methylation status of DNA and histones, which could indirectly affect the activity of v-Maf by altering gene expression patterns. Lithium chloride's inhibition of GSK-3 may stabilize the interactions between v-Maf and its coactivators or target genes, leading to increased transcriptional activity. Collectively, these activators exert their influence through a cascade of biochemical events that ultimately converge on the enhancement of v-Maf's function as a transcription factor, underscoring the intricate network of cellular signaling that governs its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can enhance transcription factors like v-Maf via phosphorylation events and alteration of downstream gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can activate PKA. PKA then may phosphorylate substrates that positively influence v-Maf activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP, potentially leading to PKA activation and subsequent enhancement of v-Maf function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on retinoic acid receptors which may heterodimerize with MAF proteins, potentially affecting v-Maf activity and target gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol, can inhibit DNA methyltransferases, potentially leading to a change in chromatin structure and enhanced access of transcription factors like v-Maf to DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an inhibitor of histone deacetylases (HDACs), which can lead to a more relaxed chromatin structure and possibly increased transcriptional activity of v-Maf. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
SAM serves as a methyl donor in various methylation reactions and can affect the methylation status of DNA and histones, potentially influencing v-Maf activity indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, potentially leading to stabilization of transcription factors and co-activators that interact with v-Maf, thereby enhancing its activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is an HDAC inhibitor that can lead to hyperacetylation of histones, potentially enhancing the transcriptional activity of v-Maf. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can inhibit HDAC activity, which may result in a chromatin structure permissive to v-Maf binding and increased transcriptional activity. | ||||||